A REVIEW ON TRANSDERMAL DRUG DELIVERY SYSTEM
Abstract
This article deals with the study of transdermal drug delivery system.  Transdermal Drug Delivery System is the system in which the delivery of the active ingredients of the drug occurs through the skin. A transdermal patch is defined as medicated adhesive patch which is placed above the skin to deliver a specific dose of medication through the skin with a predetermined rate of release to reach into the bloodstream.This article includes study of transdermal drug delivery system regarding its advantages, disadvantages, mechanism of action, types, developments, components, methods, factors affecting transdermal delivery, and its evaluation.                                               ÂReferences
Sharma Ajay, et al;†A review on Transdermal Drug Delivery System, International Journal of Research in Pharmaceutical and Biomedical Sciencesâ€,2013,4(1):286-292.
Wilkosz MF. Transdermal Drug Delivery: Part I.U.S. Pharmacist. Jobson publication; 2003;3(4):28
Darwhekar G, Jain DK, Paditar VK. Formulation and Evaluation of Transdermal drug delivery system of Clopidogrel Bisulfate. Asi. J. Pharmacy Life Sci. 2011; 1(3): 269-278.
Sachan Richa, et al;†A review on Transdermal Drug Delivery System, International Journal of Research and Development in Pharmacy and Life Sciencesâ€, 2013;3(1):748-765.
Wilson Ellen Jett,2011 Three Generations: The Past, Present, and Future of Transdermal Drug Delivery Systems. 2011
G.M., Aamer, Q., Sabale, P.M., Grampurohit, N.D., Gadhave ,M.V. Review on: recent trend on transdermal drug delivery system, Journal of Drug Delivery & Therapeutics.2012; 2(1):66-75.
Prausnitz, M.R., Langer,R. Transdermal drug delivery,Nat Biotechnol. 2008; 26(11) :1261-1268.
Vishwakarma,S.K.,NiranjanS.K.,Irchhaiya,R.,Kumar,N.,Akhtar,A.A Novel transdermal drug delivery system, International Journal of research of pharmacy 2;2(8):39-44.
Shingade,G.M.,Aamer,Q.,Sabale,P.M.,Gramprohit,N.D.,Gadhave,M.V.,Jadhv,S..L,Gaikwad, D.D.Review on: recent trend on transdermal drug delivery system, Journal of Drug Delivery & Therapeutics.2012; 2 (1):66-75.
Rastogi, V., Yadav,P., 2012. Transdermal drug delivery system: An overview, Asian Journal Of Pharmaceutics.2012; 6(3):161-170.
Mehta,R.S.,Patel,D.M.,Bhatt,K.K.,Shankar,M.B. UV and visible spectrophotometric analysis of pioglitazone hydrochloride in bulk and tablets, Indian journal of pharmaceutical sciences, 2005:87-89.
Anisree G.S, et al;â€A research on formulation and evaluation of Transdermal Drug Delivery System, Journal of pharmaceutical science and researchâ€,2012,4(10):1939-1949.
Raju R.Thenge, et al; “A Review on formulation and evaluation of transdermal drug delivery systemâ€,2010,2(1):253-258.
Robinson, J. R and Lee, H.L. (1987) Controlled Drug Delivery Fundamentals and Applications 2nd edi, Marcel Decker, New York. pp. 524-552.
Dhiman Sonia, et al; “A Review article on Transdermal Patch†International journal of pharmacy and pharmaceutical scienceâ€,2011;3(5):26-34.
Gaur PK, Mishra S, Purohit S, Dave K. Transdermal drug delivery system- A review. Asian Journal of Pharmaceutical and Clinical Research. 2009; 2:14-20.
Bavaskar Kedar, et al; “A review article on the impact of penetration enhancers on transdermal drug delivery system†International Journal of Pharma Research & Reviewâ€, 2015, 4(7):14-24.
Vyas S, Khar RK. Controlled Drug Delivery - Concept and Advances. Vallab Prakash. 2002; 418-22.
Patel Diphen, et al; “A Review on Transdermal drug delivery system†The pharma enovationâ€,2012,2(1):78-86.
Kumar J.Ashok,et al; “A review article on transdermal drug delivery system†International Journal of Pharmaceutical Sciences Review and Researchâ€,2010,3(2):49-54.
Willams A.C and barry B. W., “Penetration Enhancers,†Adv. Drug Del.Rev.2004;56: 603-618.
Berner B and John V.A. Pharmacokinetic characterization of Transdermal delivery systems. Journal Clinical pharmacokinetics 1994; 26 (2): 121-34.
Suryakumari Chalakanti, et al; “A Review Article on advance technology developing for transdermal drug delivery system†World journal of Pharmacy and Pharmaceutical scienceâ€,2014,3(7):342-358.
Barry B, 2002. Transdermal Drug Delivery, In: Aulton ME, editor. Pharmaceutics: The Science of Dosage Form Design. Churchill living stone Ltd., p.n:499-533.
Barry BW, 1983. Dermatological Formulations: New York: Marcel Dekker Vol.–18, p.n 95-120.
Güngör Sevgi, et al; “Plasticizers in Transdermal Drug Delivery Systemsâ€,2012:p.n-92-112.
Jadhav J. K, et al; “A review article on development, characterization and pharmacotechnical evaluation of transdermal drug delivery system†International journal of drug formulation and researchâ€,2011;2(4):71-92.
Foco A, Hadziabdic J, Becic F. Transdermal drug delivery systems, Med Arch 2004;58:230-234.
Davis SS. Delivery system for biopharmaceuticals, J Pharm Pharmacol 1992; 44:186-190.
Patel M. Dipen, et al; “A review article on formulation and evaluation aspect of transdermal drug delivery system†International Journal of Pharmaceutical Sciences Review and Researchâ€,2011,6(2):83-90.
Prisant L, Bottini B, Dipiro J, Carr A. Novel drug delivery system for hypertension. Am. J. Med. 2004; 93(2): 45-55.
Singh J, Tripathi KT, Sakia TR. Effect of penetration enhancers on the in vitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug. Dev. Ind. Pharm. 1993;19: 1623-8.
Wade A, Weller PJ. Handbook of pharmaceutical Excipients. Washington, DC: American Pharmaceutical Publishing Association; 1994. p.n:362-366.
Reddy RK, Muttalik S, Reddy S. Once daily sustained release matrix tablets of nicorandil: formulation and invitro evaluation. AAPS. Pharm. Sci. Tech. 2003; 4: 4.
Shaila L, Pandey S, Udupa N. Design and evaluation of matrix type membrane controlled Transdermal drug delivery system of nicotine suitable for use in smoking cessation. Indian. Journ. Pharm. Sci. 2006; 68: 179-84.
